Status and phase
Conditions
Treatments
About
The purpose of this study is to investigate the safety and immunogenicity of three different concentrations of a TBE vaccine in healthy children aged 1 to 6 years.
Sex
Ages
Volunteers
Inclusion criteria
Male and female children will be eligible for participation in this study if:
Exclusion criteria
Children will be excluded from participation in this study if they:
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal